Discontinuation report MELPHALAN FOR INJECTION
Report ID | 157136 |
Drug Identification Number | 02468921 |
Brand name | MELPHALAN FOR INJECTION |
Common or Proper name | MELPHALEN |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | BUFFER SOLUTION MELPHALAN |
Strength(s) | 10ML 50MG |
Dosage form(s) | POWDER FOR SOLUTION KIT SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 ML |
ATC code | L01AA |
ATC description | ALKYLATINGAGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2022-02-01 |
Remaining supply date | 2022-02-01 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2022-03-23 | French | Compare |
v2 | 2022-03-23 | English | Compare |
v1 | 2022-03-23 | English | Compare |
Showing 1 to 3 of 3